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Prognostic value of hemostasis-related parameters for prediction of organ dysfunction
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Background/aim: Clinical manifestations of sepsis are not caused directly by the invading pathogens, but rather mostly by systemic
inflammation that leads to activation of the coagulation system. The aim of this study was to determine whether levels of hemostasisrelated parameters measured in intensive care unit admissions are associated with mortality and severity in patients with sepsis.
Materials and methods: Eighty-five patients who fulfilled criteria for a diagnosis of sepsis were included in our study. Platelet count,
activated partial thromboplastin time (aPTT), prothrombin time (PT), thrombin time, D-dimer, and fibrinogen levels were determined
within the first 24 h from sepsis onset. Differences between groups of septic patients were assessed by Mann–Whitney U test and
Kruskal–Wallis test. Logistic regression analysis was performed to test the joint effect of different predictors.
Results: Prolonged aPTT and PT with higher D-dimer concentrations in patients with sepsis are associated with more severe forms of
the disease. aPTT was prolonged in nonsurvivors, while platelet count and fibrinogen levels were higher in survivors. Platelet count and
aPTT ratio are independent predictors of fatal outcome in our logistic regression model.
Conclusion: Hemostasis-related parameters have a significant impact on severity and outcome in sepsis.
Key words: Sepsis, hemostasis, multiple organ failure, shock, prognosis

1. Introduction
Sepsis is associated with high morbidity in intensive care
units (ICU) and the sepsis mortality rate increased in
the past decade (1). Much effort has been made to find
a useful tool that could contribute to early recognition
and complication development prediction in patients
with sepsis, in order to ease the decision-making related
to treatment (2). There are many existing clinical scores
for predicting severity and organ dysfunction in critically
ill patients and they also apply to patients with sepsis.
However, none of them have been proven to be superior to
others due to the complex pathophysiology of sepsis (3,4).
Clinical manifestations of sepsis are not caused directly
by the invading pathogens, but rather mostly by systemic
inflammation that leads to activation of the coagulation
* Correspondence: dunjamihajlovic@hotmail.com

system and inhibition of anticoagulant mechanisms and
fibrinolysis (5,6).
During sepsis, microbial products induce synthesis
and the release of inflammatory mediators. Although the
primary function of these mediators is to assist the host
in eliminating life-threatening infections, they are also
responsible for deleterious effects on the host and eventual
death (5–7).
The coagulation cascade is activated with endotoxins
and amplified by proinflammatory cytokines like
interleukin (IL)-6, tumor necrosis factor-alpha, and IL1. Thrombin generation intensifies the inflammatory
response at sites of infection and can result in disseminated
intravascular coagulation (DIC), which can be associated
with high risk of death from sepsis (8,9). Not only

93

MIHAJLOVIC et al. / Turk J Med Sci
does systemic inflammation lead to the activation of
coagulation, but the coagulation system also modulates
the inflammatory response through protease-activated cell
receptors and activation of platelets (9,10).
Data from the literature indicate that clinically relevant
coagulation abnormalities occur in 50%–70% of patients
with sepsis, while the incidence of thrombocytopenia
(platelet count of <150 × 109/L) can be found in 35%–50%
of patients and prolonged prothrombin time (PT) and/
or activated partial thromboplastin time (aPTT) occur
in 14% to 28% of patients, whereas about 35% of patients
meet the criteria for DIC (11).
Bearing in mind the importance of the intricate
relationship between systemic inflammation and
coagulation, insight into the function of hemostasis may
lead to identification of new targets for therapies that can
modify complications caused by this cross-talk (9,10).
Although there are simple laboratory tests that bring
insight into coagulation integrity, only a few studies have
researched coagulation markers that are available in the
routine hospital setting for prediction of outcome in sepsis
(8,12).
The primary aim of this study was to determine whether
levels of hemostasis-related parameters (platelet count,
aPTT, PT, thrombin time (TT), fibrinogen, D-dimer)
measured within 24 h of ICU admission are associated
with 28-day mortality in patients with sepsis.
The secondary aims of this study included evaluation
and comparison of coagulation markers and ICU scores
between different groups of septic patients according to
severity upon admission and development and persistence
of multiple organ dysfunction syndrome (MODS) in the
first 48 h.
2. Material and methods
The study was approved by the relevant ethics committee of
the Clinical Center of Vojvodina and the Medical Faculty
of Novi Sad, and all participants gave informed consent
before enrollment in the study.
2.1. Patients
Patients treated in the Department of Anesthesia and
Reanimation at the Emergency Center of the Clinical
Center of Vojvodina and in the Clinic of Infectious Disease
at the Clinical Center of Vojvodina from 1 April 2012 to 1
July 2013 with a clinical diagnosis of sepsis as defined by
the Consensus Conference Committee of the American
College of Chest Physicians/Society of Critical Care
Medicine 1992 and revised based on the International
Sepsis Definitions Conference 2001 (13,14) were eligible
for this study.
Exclusion criteria were applied to polytraumatized
patients; patients in hemorrhagic shock and patients
with malignancy, liver failure, or cardiac failure; pregnant
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women; and patients who were on anticoagulant therapy or
treated with vitamin K antagonists. Patients with systemic
inflammation caused by some other condition, like burns
and pancreatitis, were also excluded from the study.
Basic laboratory tests were performed within the first
hour of ICU admission (complete blood count, urea and
creatinine levels, bilirubin level, and concentrations of C
reactive protein and procalcitonin). The Acute Physiology
and Chronic Health Evaluation II (APACHE II) score,
Sequential Organ Failure Assessment (SOFA) score, and
Mortality Probability Model II (MPM II) were assessed
upon ICU admission.
Patients were classified into 4 groups representing
different forms of sepsis severity according to predefined
criteria upon ICU admission (13,14).
To assess the development of complications and also
the outcome of the disease, we monitored patients from
the day of sepsis development to 28 days after admission
to ICU.
2.2. Hemostasis biomarkers
Platelet count (n × 109/L) was determined as a part of
complete blood count on a CELL-DYN Sapphire ABBOT
machine by flow cytometry with commercial kits from
the same manufacturer. PT, TT, and aPTT (ratio (R))
were determined by coagulation method with IL reagents
(Instrumentation Laboratory, Italy) on ACL 9000
machines. Fibrinogen concentration (g/L) was obtained
by the Claus coagulation method with IL reagents on ACL
9000 machines. D-dimer levels (ng/mL) were determined
by latex immunoassay methodology with IL reagents.
2.3. Statistical analysis
All data were analyzed using SPSS 20.0. Data are expressed
as mean ± standard deviation (SD) or numbers (%). Since
most continuous variables were skewed, nonparametric
approaches were used. Differences between variables were
assessed by the Mann–Whitney U test and Kruskal–Wallis
test. Categorical variables were compared using the chisquare test.
To determine significant relationship between
investigated data, we used Kendall’s tau correlation.
Logistic regression analysis was performed to test the
joint effect of different predictors added to the model. All
P-values were 2-sided and statistical significance was set
at P ≤ 0.05.
3. Results
Out of the 85 patients included in this study, 50 were male
and 35 were female, all between the ages of 19 to 87 years.
Patients were classified into 4 groups, simple sepsis, severe
sepsis, septic shock, and MODS, upon admission to the
ICU. Development of MODS in the first 48 h was noted;
its persistence or resolution was noted in the groups of
patients with sepsis, severe sepsis, and septic shock.
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Table 1 shows clinical characteristics of the 4 groups
of patients according to sepsis severity on ICU admission.
The majority of patients were males, but there was no
significant sex or age difference between the groups.
Among all patients with sepsis, 28.2% developed MODS
in the first 48 h. Patients with MODS on admission and
MODS that persisted for the first 48 h were also included.
There was a significant difference between groups of septic
patients for the development of MODS (P ≤ 0.05). The
more severe form of the disease upon ICU admission
showed higher incidence of MODS development and
persistence.
The overall mortality was 29.4%. The highest mortality
was noted in the group of patients with septic shock upon
admission. There was a statistically significant difference
between the groups (P ≤ 0.05).
Comparing the levels of hemostasis-related parameters,
a significant difference was noticed between aPTT, PT, and
D-dimer levels between the groups (P ≤ 0.05). aPTT and
PT were prolonged in groups of patients with shock or
MODS present upon ICU admission, in contrast to groups
of patients with simple or severe sepsis. There was no
significant difference between platelet count, fibrinogen
level, or TT values among groups of patients with sepsis.
Severity and outcome prediction scores upon ICU
admission were also compared among the 4 groups

of septic patients. There was a statistically significant
difference for SOFA and MPM II scores, and both of these
scores were higher in patients with more severe forms of
the disease (P ≤ 0.05). However, the APACHE II score did
not differ significantly among the groups.
Since almost one-third of patients developed MODS in
the first 48 h after ICU admission, the parameters were also
compared between groups of patients with and without
MODS in the first 48 h from ICU admission (Table 2).
Results were similar to those obtained in the comparison of
the 4 groups of patients with sepsis. Statistically significant
differences were again noted for values of aPTT, PT, and
D-dimer concentration between groups with and without
MODS, as well as for values of SOFA and MPM II scores
on admission (P ≤ 0.05). Other investigated parameters
(sex, age, TT value, platelet count, fibrinogen level, and
APACHE II score) did not differ between groups with and
without MODS. As expected, mortality was significantly
higher in the group of patients with MODS in the first 48 h
than in the group without MODS (P ≤ 0.05).
Table 3 shows differences of parameters between 28day survivors and nonsurvivors. Again, there was no
significant difference between groups for age and sex.
However, comparison of hemostasis-related parameters
was different between 28-day survivors and nonsurvivors
among groups of patients with or without MODS in

Table 1. Clinical characteristics of 4 groups of studied patients according to sepsis severity at admission.
Variables

Sepsis,
n = 39

Severe sepsis,
n = 19

Septic shock,
n = 18

MODS,
n = 9 (10.6%)

Value of P

Age (years)

57.7 ± 18.2

66.8 ± 12.3

57.7 ± 12.3

57.7 ± 20.9

P > 0.05

17/22

10/9

5/13

2/7

P > 0.05

Platelet count (n × 10 /L)

229.3 ± 142.5

185.6 ± 148.6

195.7 ± 128.6

230.1 ± 198.0

P > 0.05

aPTT (R)

1.3 ± 0.5

1.3 ± 0.4

1.5 ± 0.8

2.1 ± 0.9

P = 0.002

PT (R)

1.6 ± 0.8

1.5 ± 0.4

2.2 ± 1.2

2.6 ± 1.2

P = 0.008

TT (R)

0.9 ± 0.1

0.9 ± 0.1

0.9 ± 0.2

0.9 ± 0.2

P > 0.05

Fibrinogen (g/L)

5.5 ± 1.4

4.8 ± 1.7

4.9 ± 2.2

4.3 ± 1.7

P > 0.05

D-dimer (ng/mL)

1882.9 ± 1525.7

2304.6 ± 2129

1927.9 ± 1413.9

8162.8 ± 10077.5

P = 0.020

APACHE II

13.2 ± 5.5

15.9 ± 8.1

14.4 ± 5.9

20.9 ± 9.3

P > 0.05

SOFA

3.7 ± 3.3

7.4 ± 6.4

7.4 ± 6.6

12.3 ± 10.3

P ≤ 0.001

MPM II

16.8 ± 10.6

30.2 ± 16.8

41.9 ± 13.8

58.8 ± 17.4

P ≤ 0.001

MODS in first 48 h (yes/no), n = 24

2/37 (5.4%)

4/15 (21.1%)

9/9 (50%)

9/0 (100%)

P ≤ 0.001

28 day mortality (yes/no), n = 25

2/37 (5.1%)

10/9 (52.6%)

9/9 (50%)

4/5 (44.4%)

P ≤ 0.001

Sex (F/M)
9

Data are expressed as mean ± SD or numbers. SOFA: Sequential organ failure assessment. APACHE II: Acute Physiology and Chronic Health Evaluation
II. MPM II: Mortality Probability Model II. MODS: Multiple organ dysfunction syndrome. R: Ratio.
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Table 2. Studied parameters between groups of patients with and without MODS in the first 48 h from ICU admission.
Variables

MODS absent in the first 48 h,
n = 61

MODS present in the first 48 h,
n = 24

Value of P

Age (years)

58.6 ± 16.9

60.5 ± 16.9

P > 0.05

Sex (F/M)

7/17

29/32

P > 0.05

Platelet count (n × 109/L)

220.8 ± 141.7

186.3 ± 159.1

P > 0.05

aPTT (R)

1.4 ± 0.6

1.9 ± 0.8

P = 0.006

PT (R)

1.7 ± 0.8

2.8 ± 1.2

P = 0.046

TT (R)

0.9 ± 0.2

0.8 ± 0.1

P > 0.05

Fibrinogen (g/L)

5.0 ± 1.7

5.1 ± 2.0

P > 0.05

D-dimer (ng/mL)

2537.3 ± 4352. 9

4470 ± 7027. 7

P = 0.014

APACHE II

14.6 ± 6.7

16.5 ± 8.6

P > 0.05

SOFA

4.6 ± 4.0

10.6 ± 8.8

P ≤ 0.001

MPM II

24.2 ± 17.4

46.1 ± 20.3

P ≤ 0.001

28 day mortality (yes/no), n = 26 (30.6%)

15/46 (24.6%)

11/13 (45.8%)

P = 0.04

Data are expressed as mean ± SD or numbers. SOFA: Sequential organ failure assessment. APACHE II: Acute Physiology and Chronic
Health Evaluation II. MPM II: Mortality Probability Model II. MODS: Multiple organ dysfunction syndrome. R: Ratio.

Table 3. Investigated parameters between 28-day survivors and nonsurvivors.

Variables

28-day survivors,
n = 59

28-day nonsurvivors,
n = 26

Value of P

Logistic value of P

Age (years)

57.3 ± 17.6

63.3 ± 14.4

P > 0.05

-

Sex (F/M)

23/36

12/14

P > 0.05

-

Platelet count (n × 109/L)

240.5 ± 159.3

147.3 ± 89.7

P = 0.009

P = 0.015

aPTT (R)

1.4 ± 0. 6

1.9 ± 0. 6

P = 0.007

P = 0.02

PT (R)

1.7 ± 0.9

2.0 ± 1.0

P > 0.05

-

TT (R)

0.9 ± 0.1

0.9 ± 0.2

P > 0.05

-

Fibrinogen (g/L)

5.4 ± 1.6

4.4 ± 1.9

P = 0.023

-

D-dimer (ng/mL)

2216.3 ± 1686.7

4813.4 ± 8809.2

P > 0.05

P > 0.05

APACHE II

14.7 ± 5.2

19.2 ± 9.3

P = 0.002

P = 0.024

SOFA

5.3 ± 6.1

8.6 ± 6.4

P = 0.001

-

MPM II

25.5 ± 18.6

41. 5 ± 21.0

P = 0.001

-

Data are expressed as mean ± SD or numbers. SOFA: Sequential organ failure assessment. APACHE II: Acute Physiology and Chronic
Health Evaluation II. MPM II: Mortality Probability Model II. MODS: Multiple organ dysfunction syndrome. R: Ratio.
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the first 48 h. Platelet count, aPTT ratio, and fibrinogen
levels were significantly different between survivors and
nonsurvivors (P ≤ 0.05). aPTT was prolonged significantly
in nonsurvivors, while platelet count and fibrinogen levels
were higher in survivors. Concentrations of D-dimer,
as well as PT and TT ratios, did not differ significantly
between groups of 28-day survivors and nonsurvivors.
In order to establish the potential for combinations
of investigated parameters to improve 28-day mortality
prediction, we first used Kendall’s tau correlation. aPTT
was included in the logistic regression model, while MPM
II, PT, TT, and fibrinogen were not included in the model of
logistic regression due to positive correlations with aPTT.
SOFA score significantly correlated with platelet count and
MPM II, so these 2 scores were not included in the logistic
regression model. We primarily wanted to investigate the
predictive value of hemostasis-related parameters; hence,
platelet count was a variable of interest to us more so than
SOFA score. Variables that did not differ significantly
between 28-day survivors and nonsurvivors also were not
included in the logistic regression model.
Direct logistic regression was performed in order
to assess the impact of hemostasis-related parameters
(aPTT ratio, platelet count, and D-dimer concentration)
and value of APACHE II score upon ICU admission on
the likelihood of fatal outcome within 28 days from the
onset of sepsis. The model contained 4 different variables
as predictors. The full model with all the predictors was
statistically significant (chi-square (4, N = 85) = 22.29, P
≤ 0.001). The model explains between 26.6% and 37% of
variance and could classify 76.4% of the cases correctly.
Three variables contributed significantly to the model
(platelet count, aPTT ratio, and APACHE II score), and
results are shown in Table 3. According to our results, low
platelet count and prolonged aPTT were slightly better
predictors of dying than higher APACHE II score. Low
platelet count was the strongest predictor in our model
(Table 3).
4. Discussion
MODS occurs frequently in patients with sepsis, but the
fact that sepsis may progress to MODS in certain patients,
even after the restoration of adequate organ perfusion, still
raises questions. Bearing in mind that dysregulation of a
hemostatic system may lead to microvascular thrombosis
and hypoperfusion, and that the altered fibrinolytic
mechanisms might then induce tissue ischemia and
tissue necrosis and consequently MODS, it is clear
that endothelial damage with clotting disorders is the
foundation of organ dysfunction (15,16).
ICU scoring systems are used in order to predict
patients’ outcomes based on physiological data available
at ICU admission. The value of implementation of these

scoring systems in everyday practice in order to predict
severity and outcome of critically ill patients is high
(3,4). However, hemostasis-related parameters are rarely
included in scoring systems used for prediction of sepsis
severity and outcome, except for scores that are used to
diagnose DIC (4,17,18).
In our study we focused on the evaluation of hemostasisrelated parameters for prediction of 28-day mortality and
for identifying 48-h complication development.
Our results show that prolonged PT and aPTT and
higher D-dimer concentrations upon ICU admission in
patients with sepsis are associated with more severe forms
of the disease and 48-h MODS development. SOFA and
MPM II scores also showed significant differences in the
more severe form of sepsis and complication development
in the first 48 h (Tables 1 and 2). However, the APACHE
II score, which is widely used for prediction of severity of
critical illness, was not significantly different in patients
with more severe forms of sepsis or patients with MODS
development in the first 48 h. This could be explained by
the fact that both SOFA and MPM II scores are mainly
scores for prediction of organ failure, while the APACHE
II score is more suitable for prediction of length of hospital
stay and the severity of the disease (4,15). While organ
failure is the basis of initial clinical manifestation and the
severity of sepsis, SOFA and MPM II scores recognize
more severe forms of the disease early in its development.
Positive correlations of aPTT and PT with MPM II score,
D-dimer with SOFA score, and platelet count with both
MPM II and SOFA scores imply that these markers should
be used as a part of organ dysfunction scoring systems.
Our results may indicate that the combination of existing
ICU scores with hemostasis-related parameters could
contribute to mortality and severity prediction of sepsis.
Our results also bring evidence that lower platelet
count, prolonged aPTT, and lower concentration of
fibrinogen upon ICU admission in septic patients are
significantly associated with 28-day mortality, which is
in accordance with the fact that there is extensive crosstalk between coagulation and inflammation, whereby
inflammation leads not only to activation of coagulation
but coagulation also considerably affects inflammatory
activity (11).
All observed ICU scores also showed significant
differences with higher values in the group of nonsurvivors
and this highlights the fact that the degree of organ failure
is linked to the outcome, because clinical variables that are
included in these scores are not specific just for the septic
patients (Table 3).
Platelet count and aPTT ratio on ICU admission
in patients with sepsis were proven to be independent
predictors of fatal outcome with APACHE II score in our
logistic regression model (Table 3).
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Our results demonstrate that hemostasis-related
parameters have a significant impact on severity and
outcome prediction of patients with sepsis, since
endothelial and coagulation dysfunction is essential in
pathophysiology of sepsis (19–21).
However, these easily available laboratory parameters
are not included in most commonly used ICU predictive
scoring systems (3,4). Although these scoring systems
have evolved over the past 25 years in an effort to increase
predictive accuracy and keep pace with current critical

care practice (3), we must bear in mind the fact that the
new models are not superior to the originals because they
have not included any new data elements, but they were
modified to better fit certain populations (3).
Our study, along with a few other studies that also
presented the value of hemostasis-related parameters
in sepsis (8,12), implies that a revision of ICU scoring
systems is needed and that coagulation markers should be
part of routine monitoring of patients’ clinical conditions
and progression of the critical illness.
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